Literature DB >> 15098136

Rheumatologic disease with peripheral eosinophilia.

Nüket Bavbek1, Ayşe Kargili, Handan Cipil, Ali Koşar, Yaşar Karaaslan.   

Abstract

Eosinophilia is not common in connective tissue diseases, so the frequency and clinical importance of eosinophilia in rheumatologic disease are not known. The purpose of the present review was to explore its prevalance in rheumatologic disease together with a MEDLINE database search.

Entities:  

Mesh：

Year:  2004        PMID： 15098136     DOI： 10.1007/s00296-004-0468-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  31 in total

1.  Signal transduction through interleukin-5 receptors.

Authors:  K Takatsu; N Yamaguchi; Y Hitoshi; E Sonoda; S Mita; A Tominaga
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

Review 2.  Interleukin-5, eosinophils, and disease.

Authors:  C J Sanderson
Journal:  Blood       Date:  1992-06-15       Impact factor: 22.113

3.  [Eosinophilic gastroenteritis associated with rheumatoid arthritis. Its presentation as acute abdominal pain].

Authors:  M Medina Pérez; G Novales Vasco; A Medina Pérez; F Oliva Mompeán
Journal:  Rev Esp Enferm Dig       Date:  1997-02       Impact factor: 2.086

4.  Significance of eosinophilia during gold therapy.

Authors:  P Davis; G R Hughes
Journal:  Arthritis Rheum       Date:  1974 Nov-Dec

5.  Proceedings: Eosinophilia during gold therapy.

Authors:  J D Jessop; J Dippy; A Turnbull; M Bright
Journal:  Rheumatol Rehabil       Date:  1974-05

6.  The effect of penicillamine on the laboratory parameters in rheumatoid arthritis.

Authors:  I A Jaffe
Journal:  Arthritis Rheum       Date:  1965-12

7.  Thromboangiitis obliterans with eosinophilia (Buerger's disease) of the temporal arteries.

Authors:  J T Lie; C J Michet
Journal:  Hum Pathol       Date:  1988-05       Impact factor: 3.466

8.  Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.

Authors:  V Falanga; T A Medsger
Journal:  J Am Acad Dermatol       Date:  1987-10       Impact factor: 11.527

9.  Ly1+ PRO-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo.

Authors:  R Palacios; H Karasuyama; A Rolink
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

10.  Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.

Authors:  Y Yamaguchi; T Suda; J Suda; M Eguchi; Y Miura; N Harada; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307
View more
  2 in total

Review 1.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Rojelio Mejia; Thomas B Nutman
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

Review 2.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.